MoneyWorks4Me

Vineet Laboratories - Quaterly Results

22 Jul 2025 Evaluate
The sales slipped to Rs. 74.42 millions, down -68.81% for the June 2025 quarter as against Rs. 238.62 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -8.65 millions as compared to Net Loss of Rs. -21.32 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to 3.36% as compared to -4.23% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 74.42 238.62 -68.81 74.42 238.62 -68.81 749.95 1505.91 -50.20
Other Income 0.18 3.73 -95.17 0.18 3.73 -95.17 19.87 4.63 329.16
PBIDT 3.36 -4.23 -179.43 3.36 -4.23 -179.43 -142.96 76.63 -286.56
Interest 6.12 11.37 -46.17 6.12 11.37 -46.17 39.78 47.81 -16.80
PBDT -2.76 -15.60 -82.31 -2.76 -15.60 -82.31 -182.74 28.82 -734.07
Depreciation 6.25 6.09 2.63 6.25 6.09 2.63 25.02 25.19 -0.67
PBT -9.01 -21.69 -58.46 -9.01 -21.69 -58.46 -207.76 3.63 -5823.42
TAX -0.36 -0.37 -2.70 -0.36 -0.37 -2.70 -5.85 -6.64 -11.90
Deferred Tax -0.36 -0.37 -2.70 -0.36 -0.37 -2.70 -5.85 -5.99 -2.34
PAT -8.65 -21.32 -59.43 -8.65 -21.32 -59.43 -201.91 10.27 -2066.02
Equity 92.19 92.19 0.00 92.19 92.19 0.00 92.19 92.19 0.00
PBIDTM(%) 4.51 -1.77 -354.69 4.51 -1.77 -354.69 -19.06 5.09 -474.61
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..